AZGP1 as a cancer suppressor inhibited cell proliferation, migration, and invasion via TGF-β and PTEN/Akt signaling pathways in pancreatic cancer and hepatocellular carcinoma (Kong et al., 2010; Tian et al., 2017). Here, AKT1 is linked to hepatocellular carcinoma.